Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide (Q44583967)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2003
edit
Language Label Description Also known as
English
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide
scientific article published in September 2003

    Statements

    Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide (English)
    Eugenio Cammilluzzi
    Giuseppe Lepidini

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit